Robert J. Flanagan, Director at Sagent Pharmaceuticals, Inc. (SGNT), sold 16,000 shares at $22.05 ($355K) on 2014-06-03, disclosed to the SEC on 2014-06-04.
Open-market sale of $355k SGNT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.05 | 8,000 | $176K | 49.7% |
| 2 | $22.29 | 8,000 | $178K | 50.3% |
| Total | $22.17 avg | 16,000 | $355K | 100% |
| Filing → |
| SGNT | SELL | 2014-10-08 | $505K | — | Filing → |
| SGNT | SELL | 2014-09-25 | $480K | — | Filing → |
| SGNT | SELL | 2014-09-12 | $453K | — | Filing → |